Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

The Natural History of Viral Markers in Children Infected With Human T-Lymphotropic Virus Type I in Jamaica

Go back to Resources

The Natural History of Viral Markers in Children Infected With Human T-Lymphotropic Virus Type I in Jamaica

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema

Go back to Resources

The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema

Authors:

Secondary:

Location:

URL:

Go back to Resources

The Effect of Lutein and Zeaxanthin Supplementation on Metabolites of These Carotenoids in the Serum of Persons Aged 60 or Older

Go back to Resources

The Effect of Lutein and Zeaxanthin Supplementation on Metabolites of These Carotenoids in the Serum of Persons Aged 60 or Older

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Effect of Cataract Surgery on the Development of Neovascular Age-Related Macular Degeneration (AMD)

Go back to Resources

The Effect of Cataract Surgery on the Development of Neovascular Age-Related Macular Degeneration (AMD)

Authors:

Location:

Go back to Resources

Safety and Efficacy of a Calcineurin-Inhibitor Avoidance Regimen in Pediatric Renal Transplantation

Go back to Resources

Safety and Efficacy of a Calcineurin-Inhibitor Avoidance Regimen in Pediatric Renal Transplantation

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Reading Center Evaluation of OCT Images From Patients Enrolled in the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study

Go back to Resources

Reading Center Evaluation of OCT Images From Patients Enrolled in the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study

Authors:

Location:

Go back to Resources

Association between Dietary Glycemic Index and Age-Related Macular Degeneration in Nondiabetic Participants in the Age-Related Eye Disease Study (AREDS)

Go back to Resources

Association between Dietary Glycemic Index and Age-Related Macular Degeneration in Nondiabetic Participants in the Age-Related Eye Disease Study (AREDS)

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

An Approach to Development and Dissemination of Patient Recruitment Materials for a Large Multi-Center Clinical Trial

Go back to Resources

An Approach to Development and Dissemination of Patient Recruitment Materials for a Large Multi-Center Clinical Trial

Authors:

Secondary:

Location:

Go back to Resources

A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine

Go back to Resources

A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine

Authors:

Secondary:

Location:

URL:

Go back to Resources

A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine

Go back to Resources

A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine

Authors:

Secondary:

Location:

URL:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 165
  • Page 166
  • Page 167
  • Page 168
  • Current page 169
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification